Exactech (EXAC) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Exactech Q2 2015 Revenue $61.5 Million. Net Income $3.7 Million. Diluted EPS $0.26.
July 28, 2015 4:04 PM EDTGAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $61.5 million for the second quarter of 2015, a 4% decrease from $63.9 million in the second quarter of 2014. Net income was $3.7 million, or $0.26 per diluted share, compared to $4.2 million, or $0.30 per diluted share, in the same quarter a year ago.
Second Quarter Segment Performance
The second quarter of 2015 continued to be impacted by a weakened Euro and Japanese Yen relative to the U.S.... More



